2022 Q3 Form 10-K Financial Statement

#000121390022047017 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022
Revenue $3.734K $6.424K
YoY Change -48.9%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $878.7K
YoY Change 15.22%
% of Gross Profit
Research & Development $165.1K
YoY Change 37.57%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $0.00 $165.1K
YoY Change -100.0% 37.57%
Operating Profit -$181.3K -$1.044M
YoY Change 1.83% 18.26%
Interest Expense $2.137K $10.18K
YoY Change -82.9% -58.73%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$179.7K -$1.048M
YoY Change -5.71% 16.88%
Income Tax
% Of Pretax Income
Net Earnings -$178.2K -$930.0K
YoY Change 12.43% 17.62%
Net Earnings / Revenue -4771.05% -14476.35%
Basic Earnings Per Share $0.00 -$0.02
Diluted Earnings Per Share $0.00 -$0.02
COMMON SHARES
Basic Shares Outstanding 105.7M shares 61.38M shares
Diluted Shares Outstanding 105.7M shares 61.38M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.42K
YoY Change -67.79%
Cash & Equivalents $277.3K $437.2K
Short-Term Investments
Other Short-Term Assets $393.2K
YoY Change -30.09%
Inventory
Prepaid Expenses
Receivables $1.458K
Other Receivables
Total Short-Term Assets $279.7K $439.6K $439.7K
YoY Change -40.14% -40.14%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $279.7K $439.6K $439.7K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $279.7K $439.6K $439.7K
YoY Change -40.14% -40.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $326.3K $459.3K
YoY Change 0.0% 50.13%
Accrued Expenses $63.77K $65.71K $65.71K
YoY Change -9.32% -9.33%
Deferred Revenue
YoY Change
Short-Term Debt $163.1K
YoY Change -14.7%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $895.6K $884.9K $884.9K
YoY Change 43.03% 43.03%
LONG-TERM LIABILITIES
Long-Term Debt $17.94K
YoY Change -92.18%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $17.94K
YoY Change -92.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $895.6K $884.9K $884.9K
Total Long-Term Liabilities $17.94K
Total Liabilities $895.6K $902.9K $21.40K
YoY Change 6.44% -14.09%
SHAREHOLDERS EQUITY
Retained Earnings -$5.495M -$4.433M
YoY Change 23.72%
Common Stock $586.1K $613.7K
YoY Change 5227.82% -31.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$909.8K $177.6K $418.2K
YoY Change
Total Liabilities & Shareholders Equity $279.7K $439.6K $439.7K
YoY Change -40.14% -40.14%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022
OPERATING ACTIVITIES
Net Income -$178.2K -$930.0K
YoY Change 12.43% 17.62%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$155.8K -$632.1K
YoY Change 22.83% 100.15%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $368.2K
YoY Change -57.45%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $45.00 $368.2K
YoY Change -99.84% -59.56%
NET CHANGE
Cash From Operating Activities -$155.8K -$632.1K
Cash From Investing Activities
Cash From Financing Activities $45.00 $368.2K
Net Change In Cash -$159.9K -$262.6K
YoY Change 85.46% -142.78%
FREE CASH FLOW
Cash From Operating Activities -$155.8K -$632.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-04-30
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39946
CY2022 dei Entity Registrant Name
EntityRegistrantName
SENSASURE TECHNOLOGIES, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2406468
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
505 Park Avenue
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
CY2022 dei City Area Code
CityAreaCode
(347)
CY2022 dei Local Phone Number
LocalPhoneNumber
325-4677
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
105723183 shares
CY2021Q2 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
27300 usd
CY2022Q2 sesu Prepayments And Other Receivables
PrepaymentsAndOtherReceivables
2468 usd
CY2022Q2 us-gaap Cash
Cash
46419 usd
CY2021Q2 us-gaap Cash
Cash
144129 usd
CY2022 dei Auditor Firm
AuditorFirmId
6722
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2022 dei Trading Symbol
TradingSymbol
SESU
CY2022Q2 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
390758 usd
CY2021Q2 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
555648 usd
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
583 usd
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Name
AuditorName
SRCO, C.P.A., Professional Corporation
CY2022 dei Auditor Location
AuditorLocation
NY
CY2021Q2 sesu Prepayments And Other Receivables
PrepaymentsAndOtherReceivables
6852 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
439645 usd
CY2021Q2 us-gaap Assets Current
AssetsCurrent
734512 usd
CY2022Q2 us-gaap Assets
Assets
439645 usd
CY2021Q2 us-gaap Assets
Assets
734512 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
117892 usd
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
129021 usd
CY2022Q2 sesu Accounts Payable And Accrued Liabilities To A Related Party
AccountsPayableAndAccruedLiabilitiesToARelatedParty
407163 usd
CY2021Q2 sesu Accounts Payable And Accrued Liabilities To A Related Party
AccountsPayableAndAccruedLiabilitiesToARelatedParty
249400 usd
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
76638 usd
CY2021Q2 us-gaap Loans Payable Current
LoansPayableCurrent
89838 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
86482 usd
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
101377 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
196740 usd
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
49064 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
884915 usd
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
618700 usd
CY2022Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
17935 usd
CY2021Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
229504 usd
CY2022Q2 us-gaap Liabilities
Liabilities
902850 usd
CY2021Q2 us-gaap Liabilities
Liabilities
848204 usd
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
24 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105723183 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105723183 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47295183 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47295183 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
564060 usd
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
252951 usd
CY2021Q2 us-gaap Shares Issued
SharesIssued
420000 shares
CY2021Q2 sesu Common Stock Value1
CommonStockValue1
27300 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4242504 usd
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3948919 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-195610 usd
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-284946 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4433352 usd
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3583385 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
177602 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
360863 usd
CY2022Q2 us-gaap Noncontrolling Interest In Variable Interest Entity
NoncontrollingInterestInVariableInterestEntity
-881448 usd
CY2021Q2 us-gaap Noncontrolling Interest In Variable Interest Entity
NoncontrollingInterestInVariableInterestEntity
-823298 usd
CY2022Q2 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
240641 usd
CY2021Q2 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
348743 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-463205 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-113692 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
439645 usd
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
734512 usd
CY2022 us-gaap Revenues
Revenues
6424 usd
CY2021 us-gaap Revenues
Revenues
12572 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
878712 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
762612 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
165139 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
120038 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1043851 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-882650 usd
CY2022 us-gaap Interest Expense
InterestExpense
10182 usd
CY2021 us-gaap Interest Expense
InterestExpense
24673 usd
CY2021 sesu Other Incomeexpenses
OtherIncomeexpenses
-1565 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1047609 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-896316 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1047609 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-896316 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-117648 usd
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-105642 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-929961 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-790674 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.015
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61379022 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15792612 shares
CY2022 us-gaap Profit Loss
ProfitLoss
-1047609 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-896316 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
120726 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-77982 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-926883 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-974298 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
840625 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
851189 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-86258 usd
CY2021 sesu Issuance Of Shares Pursuant To Private Placement One
IssuanceOfSharesPursuantToPrivatePlacementOne
27300 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-123109 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-926883 usd
CY2021 sesu Issuance Of Class A Preferred Shares For Services
IssuanceOfClassAPreferredSharesForServices
360795 usd
CY2021 sesu Issuance Of Stock Options To Settle Debts By Subsidiary
IssuanceOfStockOptionsToSettleDebtsBySubsidiary
326337 usd
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-914919 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-77982 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-113692 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-974298 usd
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-728237 usd
CY2021 sesu Issuance Of Shares Pursuant To Private Placement Note4 And Note8b
IssuanceOfSharesPursuantToPrivatePlacementNote4AndNote8b
99643 usd
CY2021 sesu Subsidiary Issuance Of Shares Pursuant To Private Placement
SubsidiaryIssuanceOfSharesPursuantToPrivatePlacement
27671 usd
CY2021 sesu Issuance Of Shares Pursuant To Private Placements
IssuanceOfSharesPursuantToPrivatePlacements
765700 usd
CY2022 sesu Issuance Of Shares Pursuant To Private Placement Note4 And Note8b
IssuanceOfSharesPursuantToPrivatePlacementNote4AndNote8b
340900 usd
CY2022 sesu Amortization Of Vested Shares
AmortizationOfVestedShares
88210 usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
148260 usd
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1047609 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
120726 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-463205 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-1047609 usd
CY2021 us-gaap Profit Loss
ProfitLoss
-896316 usd
CY2021 sesu Issuance Of Class A Preferred Shares For Service
IssuanceOfClassAPreferredSharesForService
360795 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
88210 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
148260 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-549 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
557 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3728 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3742 usd
CY2022 sesu Accounts Payable And Accrued Liabilities To Third Parties And A Related Party
AccountsPayableAndAccruedLiabilitiesToThirdPartiesAndARelatedParty
196586 usd
CY2021 sesu Accounts Payable And Accrued Liabilities To Third Parties And A Related Party
AccountsPayableAndAccruedLiabilitiesToThirdPartiesAndARelatedParty
202029 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
174423 usd
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-197578 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-196266 usd
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
219549 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-632119 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-315820 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
368200 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
865343 usd
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
27671 usd
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
28125 usd
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
45638 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
368200 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
910527 usd
CY2022 sesu Effect Of Exchange Rate Changes On Cash And Restricted Cash Held In Trust
EffectOfExchangeRateChangesOnCashAndRestrictedCashHeldInTrust
1319 usd
CY2021 sesu Effect Of Exchange Rate Changes On Cash And Restricted Cash Held In Trust
EffectOfExchangeRateChangesOnCashAndRestrictedCashHeldInTrust
19108 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-262600 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
613815 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
699777 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85962 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
437177 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
699777 usd
CY2021 us-gaap Stock Issued1
StockIssued1
326337 usd
CY2020Q4 sesu Description Of Share Exchange Agreement
DescriptionOfShareExchangeAgreement
the Company completed a reverse recapitalization via a share exchange agreement with Sensa Bues AB and the shareholders who owned 270,339 common shares that represented 72.82% of the total issued and outstanding common shares in Sensa Bues AB. Under the share exchange agreement, the shareholders of Sensa Bues AB, agreed to exchange their shares of Sensa Bues AB for common shares of SensaSure at an exchange ratio of approximate 1:49.99. Pursuant to the share exchange transactions (see share exchange agreement noted above), SensaSure issued a total of 13,515,183 common shares and the then-shareholders of Sensa Bues AB hold their ownership of Sensa Bues AB through SensaSure (Note 9 (b)). Upon completion of the share exchange transaction, SensaSure became the controlling shareholder that owned 74.82% the total issued and outstanding common shares in Sensa Bues AB and parent company of Sensa Bues AB (“Subsidiary”).
CY2022Q2 sesu Common Stock Share Issued
CommonStockShareIssued
2200000 shares
CY2022 sesu Common Shares Noncontrolling Interests
CommonSharesNoncontrollingInterests
440 shares
CY2022Q2 sesu Percentage Of Common Shares Outstanding
PercentageOfCommonSharesOutstanding
0.74 pure
CY2021Q2 sesu Percentage Of Common Shares Outstanding
PercentageOfCommonSharesOutstanding
0.74 pure
CY2022Q2 sesu Workings Capital Deficiency
WorkingsCapitalDeficiency
445270 usd
CY2022Q2 sesu Working Capital Surplus
WorkingCapitalSurplus
115812 usd
CY2022Q2 sesu Several Private Placements
SeveralPrivatePlacements
368200 usd
CY2021Q2 sesu Several Private Placements
SeveralPrivatePlacements
893014 usd
CY2022Q2 us-gaap Gas Imbalance Payable Current And Noncurrent
GasImbalancePayableCurrentAndNoncurrent
333744 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
326337 usd
CY2021Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
56555 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65714 usd
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72466 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
117892 usd
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
129021 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical management judgment and use of estimates</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Areas involving significant estimates and assumptions include: deferred income tax assets and related valuation allowance, accruals, stock options, principles of consolidation and reverse recapitalization and assumptions used in the going concern assessment. Actual results could differ from those estimates. These estimates are reviewed periodically, and, as adjustments become necessary, they are reported in earnings in the period in which they become known.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p>
CY2022Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
52178 usd
CY2021 sesu Proceeds Net
ProceedsNet
793000 usd
CY2021 sesu Proceed From Issuance Of Common Stock
ProceedFromIssuanceOfCommonStock
12200000 shares
CY2021 sesu Issued Of Common Shares
IssuedOfCommonShares
11780000 shares
CY2021Q2 sesu Proceeds Received In Common Stock
ProceedsReceivedInCommonStock
117800 usd
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
647900 usd
CY2021Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
27300 usd
CY2022 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
420000 shares
CY2022Q2 sesu Proceeds Received From Common Stock Issued
ProceedsReceivedFromCommonStockIssued
420000 shares
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
29811 usd
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
293000 sek
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
34945 usd
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Fair Value
RedeemableNoncontrollingInterestEquityFairValue
293000 sek
CY2022Q2 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.20 pure
CY2022 us-gaap Interest Expense Other
InterestExpenseOther
6580 usd
CY2021 us-gaap Interest Expense Other
InterestExpenseOther
6686 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.248 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.2118 pure
CY2022 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-1047609 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-896316 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.248 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2118 pure
CY2022 sesu Income Tax Recoverable
IncomeTaxRecoverable
259848 usd
CY2021 sesu Income Tax Recoverable
IncomeTaxRecoverable
189852 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
66212 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
75767 usd
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
46991 usd
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-24666 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
146645 usd
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
138751 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
812320 usd
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
665675 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
812320 usd
CY2021 us-gaap Federal State And Local Income Tax Expense Benefit Continuing Operations
FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations
3113044 usd
CY2021Q1 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
326337 usd
CY2021Q1 sesu Aggregated Shares
AggregatedShares
3400 shares
CY2021Q1 sesu Number Of Common Shares
NumberOfCommonShares
50 shares
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
665675 usd
CY2022 us-gaap Federal State And Local Income Tax Expense Benefit Continuing Operations
FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations
3814457 usd
CY2021 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
3001 usd
CY2021Q2 us-gaap Notes Payable
NotesPayable
713 usd
CY2022Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
55959 usd
CY2022Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
550000 sek
CY2021Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
65597 usd
CY2021Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
550000 sek
CY2022 sesu Unsecured Bearing Interest
UnsecuredBearingInterest
0.02 pure
CY2022 sesu Related Party Transaction Description
RelatedPartyTransactionDescription
At April 30, 2022 and April 30, 2021, balances of loan from a former director of SensaSure were $30,523 (SEK 300,000) and $35,780 (SEK 300,000), respectively. The loan is unsecured, bearing interest at 2% per annum and due on demand. The interest expense was $674 and $742 for year ended April 30, 2022 and April 30, 2021, respectively. 
CY2021Q2 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
138483 usd
CY2021Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
249400 usd
CY2021 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
13066 usd
CY2021 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
120038 usd
CY2021Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
333744 usd
CY2021Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
2798280 sek
CY2022Q2 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
6997 usd
CY2021Q2 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
6677 usd
CY2022Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
17935 usd
CY2022Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
176280 sek
CY2021Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
229504 usd
CY2021Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
1924280 sek
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
17935 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
17935 usd
CY2022Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
407163 usd
CY2022 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
165139 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.07
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
105723183 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105723183 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47295183 shares
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
99643 usd
CY2021 sesu Common Shares To Noncontrolling Interests
CommonSharesToNoncontrollingInterests
10000 shares
CY2021Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
499935 shares
CY2021 us-gaap Proceeds From Customers
ProceedsFromCustomers
4999 usd
CY2021Q2 us-gaap Common Stocks Including Additional Paid In Capital Net Of Discount
CommonStocksIncludingAdditionalPaidInCapitalNetOfDiscount
94644 usd
CY2020Q4 sesu Owned Common Shares
OwnedCommonShares
270339 shares
CY2020Q4 sesu Owned Common Shares Percentage
OwnedCommonSharesPercentage
0.7282 pure
CY2020Q4 us-gaap Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares
StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares
13515183 shares
CY2021 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
793000 usd
CY2021 us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
12200000 shares
CY2021 us-gaap Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares
StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares
11780000 shares
CY2021 sesu Agreement Description
AgreementDescription
The proceeds received was reflected as an increase in common stock in amount of $117,800 and additional paid-in capital in amount of $647,900 respectively. The Company recognized a subscription receivable in amount of $27,300 as well as shares to be issued at April 30, 2021. The number of shares to be issued was 420,000. The Company received the subscription proceeds subsequently to year end and issued 420,000 common shares accordingly (Note 4). The subscribers entered into lock up agreement pursuant to which (1) The Shareholders shall 1,715,800 of the shares subscribed to sell when a trading market begins on the OTC Markets; (ii) The Shareholders shall have 5,346,000 of their remaining shares available to sell Six (6) months after the initial listing date of the shares on the NASDAQ Market; (iii) The Shareholders shall have their remaining shares for trading Eighteen (18) months after the initial listing date of the shares on the NASDAQ Market; and (iv) In the event the stock does not begin trading on the NASDAQ Market within a period of Thirty-Six (36) months after the execution of the Share Exchange Agreement, the Shareholders shall have up to Thirty Percent (30%) of their remaining shares available to sell after the initial listing date of the shares on the OTC Market. The balance of the Shareholder’s shares shall be available for trading Sixty (60) months after the initial listing date of the shares on the OTC Market (the “Lock Up Period”).
CY2022 sesu Shares Available Description
SharesAvailableDescription
After the revision, the shareholders shall have 10,898,736 shares available to sell upon a trading market begins on OTC Market, 7,738,000 shares available to sell upon six months after a trading market begins on OTC Market, 4,750,000 shares available to sell upon initial listing date on the Nasdaq Market, 6,280,000 shares available to sell upon six months after initial listing date on the Nasdaq Market, 800,000 shares available to sell upon twelve months after initial listing date on the Nasdaq Market, 3,838,213 shares available to sell upon eighteen months after the initial listing date on Nasdaq Market, 6,620,863 shares available to sell upon twenty four months after the initial listing date on Nasdaq Market and the balance of the shareholders’ shares will be available to sell upon sixty months after the initial listing date on Nasdaq Market.
CY2021Q2 sesu Fair Value Of Shares Issued Amount
FairValueOfSharesIssuedAmount
502614 usd
CY2022 sesu Unvested Shares
UnvestedShares
7931000 shares
CY2022 sesu Share Based Compensation Expenses
ShareBasedCompensationExpenses
88210 usd
CY2022Q2 sesu Common Stock In Amount
CommonStockInAmount
38610 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
49600 usd
CY2021 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
31500 shares
CY2022Q2 sesu Common Shares
CommonShares
50 shares
CY2022 sesu Issuance Of Description
IssuanceOfDescription
The Company recognized a subscription receivable in amount of $27,300 as well as shares to be issued at April 30, 2021. The number of shares to be issued was 420,000. The Company received the subscription proceeds during the year ended April 30, 2022 and issued 420,000 common shares accordingly (Note 4). During the year ended April 30, 2022, SensaSure, via several private placements, raised proceeds of $340,900 ($0.07 per share) and issued 4,870,000 common shares. The proceeds received was reflected as an increase in common stock in amount of $3,409 and additional paid-in capital in amount of $337,491 respectively. The subscribers entered into lock up agreement and the shareholders shall have 502,584 shares available to sell upon a trading market begins on OTC Market, 356,484 shares available to sell upon six months after a trading market begins on OTC Market, 218,663 shares available to sell upon initial listing date on the Nasdaq Market, 289,278 shares available to sell upon six months after initial listing date on the Nasdaq Market, 37,012 shares available to sell upon twelve months after initial listing date on the Nasdaq Market, 176,781 shares available to sell upon eighteen months after the initial listing date on Nasdaq Market, 304,862 shares available to sell upon twenty four months after the initial listing date on Nasdaq Market and the balance of the shareholders’ shares will be available to sell upon sixty months after the initial listing date on Nasdaq Market. On January 31, 2022, the board of directors of the Company has discussed and approved the conversion of the classes A preferred stock to be done prior to filing an application to the OTC Markets for trading on the OTC Markets ATS. Conversion was completed on January 31, 2022 and Class A preferred stock were converted into 24,371,000 of common shares of the Company. All service conditions and lock up period applied to each of the issuances remained unchanged. On January 31, 2022, the board of directors of the Company has discussed and approved the conversion of the classes B preferred stock to be done prior to filing an application to the OTC Markets for trading on the OTC Markets ATS. Conversion was completed on January 31, 2022 and Class B preferred stock were converted into 31,500,000 of common shares of the Company. All service conditions and lock up period applied to each of the issuances remained unchanged. As at April 30, 2022, the vesting conditions have not been met. During the year ended April 30, 2022, the Company approved the issuance of 2,118,000 shares of the common stock to several consultants and directors. The fair value of the share-based compensation was in the amount of $148,260 and was included in the general and admirative expenses as well as a credit made in common stock in amount of 21,180 and additional paid-in capital in amount of 127,080 respectively. The fair value of the shares of common stock issued was determined by using the most recent private placement price at $0.07 per share. One of the consultants is a related party individual and the share awards was 2,100,000 common shares with an amount of 147,000. 
CY2022 sesu Sensa Sure Issued Common Shares
SensaSureIssuedCommonShares
3080000 shares
CY2022 sesu Common Shareholders Of The Company Percentage
CommonShareholdersOfTheCompanyPercentage
0.74 pure
CY2021 sesu Common Shareholders Of The Company Percentage
CommonShareholdersOfTheCompanyPercentage
0.74 pure
CY2020 sesu Common Shareholders Of The Company Percentage
CommonShareholdersOfTheCompanyPercentage
0.73 pure
CY2022Q2 sesu Noncontrolling Interests Percentage
NoncontrollingInterestsPercentage
0.26 pure
CY2021Q2 sesu Noncontrolling Interests Percentage
NoncontrollingInterestsPercentage
0.26 pure
CY2020Q2 sesu Noncontrolling Interests Percentage
NoncontrollingInterestsPercentage
0.27 pure
CY2022 sesu Net Loss Of Sensa Bues Ab Attributable To The Company
NetLossOfSensaBuesABAttributableToTheCompany
-334818 shares
CY2021 sesu Net Loss Of Sensa Bues Ab Attributable To The Company
NetLossOfSensaBuesABAttributableToTheCompany
-300649 shares
CY2021 sesu Increase In The Companys Accumulated Deficit For Sensa Bues Ab Issuance Of Common Shares To
IncreaseInTheCompanysAccumulatedDeficitForSensaBuesABIssuanceOfCommonSharesTo
-34524 shares
CY2022 sesu Change From Net Loss Attributable To The Company And Transfer From Noncontrolling Interests
ChangeFromNetLossAttributableToTheCompanyAndTransferFromNoncontrollingInterests
-334818 shares
CY2021 sesu Change From Net Loss Attributable To The Company And Transfer From Noncontrolling Interests
ChangeFromNetLossAttributableToTheCompanyAndTransferFromNoncontrollingInterests
-335173 shares
CY2022Q2 sesu Common Stock Share Issued
CommonStockShareIssued
2200000 shares
CY2022 sesu Common Shares Noncontrolling Interests
CommonSharesNoncontrollingInterests
440 shares
CY2022Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
220000 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q2 sesu Preferred Stock Value1
PreferredStockValue1
usd
CY2021Q2 sesu Preferred Stock Value1
PreferredStockValue1
usd
CY2022Q2 sesu Common Stock Value1
CommonStockValue1
usd
CY2022Q2 us-gaap Shares Issued
SharesIssued
shares
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.015
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.050
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15792612 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61379022 shares
CY2021 sesu Subsidiary Issuance Of Shares Pursuant To Private Placement One
SubsidiaryIssuanceOfSharesPursuantToPrivatePlacementOne
usd
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
usd
CY2021 sesu Effect Of Dilution Of Ownership In Subsidiary Pursuant To Issuance Of Shares
EffectOfDilutionOfOwnershipInSubsidiaryPursuantToIssuanceOfShares
usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2022 sesu Issuance Of Class A Preferred Shares For Service
IssuanceOfClassAPreferredSharesForService
usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2021Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2022 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
usd
CY2022 sesu Increase In The Companys Accumulated Deficit For Sensa Bues Ab Issuance Of Common Shares To
IncreaseInTheCompanysAccumulatedDeficitForSensaBuesABIssuanceOfCommonSharesTo
shares
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001885336
CY2021Q4 dei Entity Public Float
EntityPublicFloat
0 usd

Files In Submission

Name View Source Status
0001213900-22-047017-index-headers.html Edgar Link pending
0001213900-22-047017-index.html Edgar Link pending
0001213900-22-047017.txt Edgar Link pending
0001213900-22-047017-xbrl.zip Edgar Link pending
f10k2022ex21-1_sensasuretech.htm Edgar Link pending
f10k2022ex23-1_sensasuretech.htm Edgar Link pending
f10k2022ex31-1_sensasuretech.htm Edgar Link pending
f10k2022ex31-2_sensasuretech.htm Edgar Link pending
f10k2022ex32-1_sensasuretech.htm Edgar Link pending
f10k2022_sensasuretech.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
f10k2022_sensasuretech_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sesu-20220430.xsd Edgar Link pending
Show.js Edgar Link pending
sesu-20220430_pre.xml Edgar Link unprocessable
sesu-20220430_lab.xml Edgar Link unprocessable
sesu-20220430_cal.xml Edgar Link unprocessable
sesu-20220430_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable